Avita Medical Inc (RCEL) Stock Price, Quote & News

Company Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to...

Industry: Medical Devices

Sector: Healthcare

Phone: 661 367 9170

Fax: 661 367 9180

Website: avitamedical.com

Address:

28159 Avenue Stanford, Suite 220, Valencia, United States

JHR Mar. 18 at 7:38 PM

$RCEL Good time to stock up on RECELL just in case!!!

0 · Reply

commoncentsinvestor Mar. 18 at 6:18 PM

$RCEL Based upon projected 2026 revenue estimate of $82M and a current Market Cap of $137M and with Gross Margins of 82%, a 1.6 Price to Sales ratio makes RCEL a very, very undervalued play at its current price of $4.22. Those able to purchase at this price should have a good chance of having large profits going forward.

0 · Reply

scottgrant2 Mar. 18 at 4:21 PM

$RCEL had to sell to volatile.. man love this company but no one holds

1 · Reply

scottgrant2 Mar. 6 at 12:56 AM

$RCEL not to put my reputation on it but I will.. this stock going to close the gaps on the way up

0 · Reply

bemore Mar. 5 at 6:19 PM

$RCEL Northland Capital initiates coverage with $10 target eom

0 · Reply

scottgrant2 Mar. 2 at 8:05 PM

$RCEL cup and handle? Bull flag? On the daily.. shit.. this could go over 8-10

0 · Reply

scottgrant2 Feb. 28 at 12:06 AM

$RCEL I think there is a lot more upside..

0 · Reply

JHR Feb. 27 at 4:39 PM

$RCEL How is RCEL product distribution looking in Iran?

0 · Reply

Greenblacks Feb. 25 at 3:57 PM

$RCEL im out...wrong direction

1 · Reply

topstockalerts Feb. 24 at 7:32 PM

$RCEL story is all about execution showing up in numbers. If updates confirm progress, institutions start paying attention. Defined milestones give it structure. Could see this building ahead of clarity.

0 · Reply

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

Feb 12, 2026, 4:01 PM EST - 5 weeks ago

AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

Jan 13, 2026, 8:25 AM EST - 2 months ago

AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook

Jan 5, 2026, 4:05 PM EST - 2 months ago

AVITA Medical Announces Changes to its Board of Directors

Dec 18, 2025, 4:15 PM EST - 3 months ago

AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 24, 2025, 4:15 PM EST - 4 months ago

AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference

Nov 3, 2025, 8:30 AM EST - 4 months ago

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment

Oct 29, 2025, 4:15 PM EDT - 5 months ago

AVITA Medical to Announce Third Quarter 2025 Financial Results

Oct 28, 2025, 4:30 PM EDT - 5 months ago

AVITA Medical Welcomes Support for RECELL® in Burns in Australia

Oct 16, 2025, 6:15 PM EDT - 5 months ago

AVITA Medical Announces CEO Transition

Oct 16, 2025, 5:43 PM EDT - 5 months ago

AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Oct 9, 2025, 12:49 PM EDT - 5 months ago

AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Oct 1, 2025, 8:30 AM EDT - 6 months ago

CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

Sep 11, 2025, 3:31 PM EDT - 6 months ago

RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm

Sep 9, 2025, 3:47 PM EDT - 6 months ago

AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm

Aug 21, 2025, 4:05 PM EDT - 7 months ago

AVITA Medical Announces September Investor Conference Participation

Aug 12, 2025, 8:30 AM EDT - 7 months ago

AVITA Medical Successfully Completes Australian Equity Raise

Aug 10, 2025, 7:00 PM EDT - 7 months ago

AVITA Medical to Host Investor Webinar Briefing

Aug 7, 2025, 4:05 PM EDT - 8 months ago

AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation

Jul 28, 2025, 4:05 PM EDT - 8 months ago

AVITA Medical to Announce Second Quarter 2025 Financial Results

Jun 3, 2025, 8:00 PM EDT - 10 months ago

AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards

May 8, 2025, 4:03 PM EDT - 11 months ago

AVITA Medical Reports First Quarter 2025 Financial Results

Apr 17, 2025, 4:05 PM EDT - 1 year ago

AVITA Medical to Announce First Quarter 2025 Financial Results

Apr 9, 2025, 4:05 PM EDT - 1 year ago

AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025

Apr 3, 2025, 4:03 PM EDT - 1 year ago

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

Mar 17, 2025, 4:05 PM EDT - 1 year ago

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific

Feb 26, 2025, 5:30 PM EST - 1 year ago

AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference

Feb 13, 2025, 4:01 PM EST - 1 year ago

AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 8, 2025, 1:06 PM EST - 1 year ago

Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals

Jan 8, 2025, 8:14 AM EST - 1 year ago

AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Jan 7, 2025, 10:12 PM EST - 1 year ago

AVITA Medical's shares sink 19% after another forecast cut

Jan 7, 2025, 4:35 PM EST - 1 year ago

AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

Dec 23, 2024, 4:02 PM EST - 1 year ago

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

Dec 19, 2024, 5:05 PM EST - 1 year ago

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

Dec 18, 2024, 4:08 PM EST - 1 year ago

AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 25, 2024, 4:02 PM EST - 1 year ago

AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference

Nov 12, 2024, 4:03 PM EST - 1 year ago

AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand

Nov 7, 2024, 4:03 PM EST - 1 year ago

AVITA Medical Reports Third Quarter Financial Results

Oct 10, 2024, 5:15 PM EDT - 1 year ago

AVITA Medical to Announce Third Quarter 2024 Financial Results

Sep 12, 2024, 4:05 PM EDT - 1 year ago

AVITA Medical to Present at 2024 Cantor Global Healthcare Conference

Sep 10, 2024, 4:03 PM EDT - 1 year ago

AVITA Medical to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference

Aug 8, 2024, 4:04 PM EDT - 1 year ago

AVITA Medical Reports Second Quarter Financial Results

Jul 11, 2024, 4:10 PM EDT - 1 year ago

AVITA Medical to Announce Second Quarter 2024 Financial Results

JHR Mar. 18 at 7:38 PM

$RCEL Good time to stock up on RECELL just in case!!!

0 · Reply

commoncentsinvestor Mar. 18 at 6:18 PM

0 · Reply

scottgrant2 Mar. 18 at 4:21 PM

$RCEL had to sell to volatile.. man love this company but no one holds

1 · Reply

scottgrant2 Mar. 6 at 12:56 AM

$RCEL not to put my reputation on it but I will.. this stock going to close the gaps on the way up

0 · Reply

bemore Mar. 5 at 6:19 PM

$RCEL Northland Capital initiates coverage with $10 target eom

0 · Reply

scottgrant2 Mar. 2 at 8:05 PM

$RCEL cup and handle? Bull flag? On the daily.. shit.. this could go over 8-10

0 · Reply

scottgrant2 Feb. 28 at 12:06 AM

$RCEL I think there is a lot more upside..

0 · Reply

JHR Feb. 27 at 4:39 PM

$RCEL How is RCEL product distribution looking in Iran?

0 · Reply

Greenblacks Feb. 25 at 3:57 PM

$RCEL im out...wrong direction

1 · Reply

topstockalerts Feb. 24 at 7:32 PM

0 · Reply

Wats_Up Feb. 24 at 5:00 PM

$RCEL Hot dang. Maybe the long path upward is finally here. Thank you new CEO (interim or perm?). Bringing back credibility.

0 · Reply

topstockalerts Feb. 23 at 9:55 PM

After Hours Top Gainers PT2 $RCEL $DEFT $IONL $MRNO $GAME

0 · Reply

scottgrant2 Feb. 20 at 10:22 PM

$RCEL

0 · Reply

BillionerOfKing Feb. 20 at 10:17 PM

$RCEL Current Stock Price: $4.80 Contracts to trade: $5.0 RCEL Feb 20 2026 Call Entry: $0.03 Exit: $0.04 ROI: 61% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

topstockalerts Feb. 20 at 7:13 PM

$RCEL Showing strong relative strength versus the market. It’s holding gains while others chop. That’s a bullish sign.

0 · Reply

JHR Feb. 20 at 4:17 PM

$RCEL

0 · Reply

Scipio79 Feb. 19 at 10:58 PM

$RCEL lfg

0 · Reply

scottgrant2 Feb. 19 at 8:48 PM

$RCEL changed to buy rating at Zack’s

0 · Reply

commoncentsinvestor Feb. 17 at 4:00 PM

$RCEL VALENCIA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced data from 19 scientific abstracts, including 14 podium presentations, at the 2026 Boswick Burn & Wound Symposium. The presentations include the first surgeon-reported integrated use of all three AVITA Medical technologies – RECELL, PermeaDerm, and Cohealyx – in individual patient cases, as well as clinical and tissue-level findings from separate studies evaluating PermeaDerm and Cohealyx. https://ir.avitamedical.com/news-releases/news-release-details/data-2026-boswick-burn-wound-symposium-highlight-first

0 · Reply

PortfolioSpectrum Feb. 17 at 2:38 PM

$RCEL Avita Medical regenerative medicine; commercial adoption of burn care device key.

0 · Reply

Fmello Feb. 16 at 4:06 AM

$RCEL - Just noticed that the Aussie stock is up 12.96% so far tonight.

0 · Reply

Market Cap	121.00M
Revenue (ttm)	71.61M
Net Income (ttm)	-48.59M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-67.85%
Debt to Equity Ratio	-2.58

Volume	296,100
Avg Vol	232,826
Day's Range	N/A - N/A
Shares Out	30.63M
Stochastic %K	8%
Beta	1.77
Analysts	Sell
Price Target	$7.25